AC
VSEEW

Aristeia Capital’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Aristeia Capital’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250,000
Closed -$26K – 706
2022
Q2 		$26K Hold
250,000
– – ﹤0.01% 598
2022
Q1 		$37K Buy
+250,000
New +$58.5K ﹤0.01% 670

Other funds holding VSEEW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Aristeia Capital's VSEEW Position: Q3 2022 in Review

Aristeia Capital sold out of VSEE HEALTH INC WTS 29 (VSEEW) in Q3 2022, closing a stake of 250,000 shares — an estimated $26K sold.

Aristeia Capital first reported a position in VSEEW in Q1 2022 and held it in 2 quarters. The position peaked at $37K in Q1 2022. 30 funds tracked by Wall St. Rank hold VSEEW as of Q3 2022.

  • Aristeia Capital reported no remaining VSEE HEALTH INC WTS 29 position as of Q3 2022 after selling out during the quarter.
  • Aristeia Capital sold 250,000 VSEE HEALTH INC WTS 29 shares in Q3 2022, an estimated $26K.
  • Aristeia Capital first reported a position in VSEE HEALTH INC WTS 29 in Q1 2022 and held it in 2 quarters.
  • Aristeia Capital's VSEE HEALTH INC WTS 29 position peaked at $37K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q3 2022.

Based on Aristeia Capital's 13F filing for Q3 2022, filed 14 Nov 2022.